Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Repeat Dose, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men

NCT00695110 is registered in ClinicalTrials.gov with Clarus Therapeutics, Inc. as lead sponsor.

NCT NCT00695110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00695110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Repeat Dose, Pharmacokinetic Study of Oral Testosterone Ester Formulations in Hypogonadal Men
Lead sponsor
Clarus Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2008
Completion date
August 31, 2009
Enrollment
29 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism